NO173501C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrazolo-pyridinforbindelser - Google Patents
Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrazolo-pyridinforbindelserInfo
- Publication number
- NO173501C NO173501C NO895165A NO895165A NO173501C NO 173501 C NO173501 C NO 173501C NO 895165 A NO895165 A NO 895165A NO 895165 A NO895165 A NO 895165A NO 173501 C NO173501 C NO 173501C
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- therapeutically active
- pyridine compounds
- analogous procedures
- active pyrazolo
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10309088 | 1988-04-26 | ||
JP27143988 | 1988-10-27 | ||
JP1684689 | 1989-01-26 | ||
PCT/JP1989/000423 WO1989010365A1 (en) | 1988-04-26 | 1989-04-19 | Pyrazolopyridine type mevalonolactones |
Publications (4)
Publication Number | Publication Date |
---|---|
NO895165D0 NO895165D0 (no) | 1989-12-21 |
NO895165L NO895165L (no) | 1989-12-21 |
NO173501B NO173501B (no) | 1993-09-13 |
NO173501C true NO173501C (no) | 1993-12-22 |
Family
ID=27281590
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO895165A NO173501C (no) | 1988-04-26 | 1989-12-21 | Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrazolo-pyridinforbindelser |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0339358B1 (no) |
JP (1) | JP2890448B2 (no) |
KR (1) | KR970009222B1 (no) |
AT (1) | ATE108450T1 (no) |
DE (1) | DE68916685T2 (no) |
DK (1) | DK659089A (no) |
FI (1) | FI90870C (no) |
HU (1) | HU203888B (no) |
NO (1) | NO173501C (no) |
WO (1) | WO1989010365A1 (no) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3130342B2 (ja) * | 1991-10-04 | 2001-01-31 | 日産化学工業株式会社 | 動脈硬化性血管内膜肥厚抑制薬 |
US6949648B2 (en) | 2000-03-27 | 2005-09-27 | Takeda Pharmaceutical Company Limited | Condensed pyrazole derivatives, process for producing the same and use thereof |
EP2170884A2 (en) * | 2007-06-25 | 2010-04-07 | Boehringer Ingelheim International GmbH | Chemical compounds |
ES2389992T3 (es) | 2007-11-02 | 2012-11-05 | Vertex Pharmaceuticals Incorporated | Derivados de [1H-pirazolo[3,4-b]piridin-4-il]-fenilo o -piridin-2-ilo como proteína cinasa c-theta |
CN105732639A (zh) | 2012-06-29 | 2016-07-06 | 辉瑞大药厂 | 作为LRRK2抑制剂的4-(取代的氨基)-7H-吡咯并〔2,3-d〕嘧啶类 |
EP3083618B1 (en) | 2013-12-17 | 2018-02-21 | Pfizer Inc | Novel 3,4-disubstituted-1h-pyrrolo[2,3-b]pyridines and 4,5-disubstituted-7h-pyrrolo[2,3-c]pyridazines as lrrk2 inhibitors |
JP6873980B2 (ja) | 2015-09-14 | 2021-05-19 | ファイザー・インク | LRRK2阻害薬としての新規のイミダゾ[4,5−c]キノリンおよびイミダゾ[4,5−c][1,5]ナフチリジン誘導体 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU204253B (en) * | 1982-11-22 | 1991-12-30 | Sandoz Ag | Process for producing mevalonolactone analogues and derivatives and pharmaceutical compositions containing them |
WO1986000307A2 (en) * | 1984-06-22 | 1986-01-16 | Sandoz Ag | Pyrazole analogs of mevalonolactone and derivatives thereof, processes for their production and their use |
US4761419A (en) * | 1987-12-07 | 1988-08-02 | Warner-Lambert Company | 6-(((substituted)quinolinyl)ethyl)-and ethenyl)tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis |
US4822799A (en) * | 1988-01-27 | 1989-04-18 | Sandoz Pharm. Corp. | Pyrazolopyridine analogs of mevalonolactone and derivatives thereof useful for inhibiting cholesterol biosynthesis in mammals |
-
1989
- 1989-04-07 JP JP1088534A patent/JP2890448B2/ja not_active Expired - Fee Related
- 1989-04-11 DE DE68916685T patent/DE68916685T2/de not_active Expired - Fee Related
- 1989-04-11 EP EP89106401A patent/EP0339358B1/en not_active Expired - Lifetime
- 1989-04-11 AT AT89106401T patent/ATE108450T1/de not_active IP Right Cessation
- 1989-04-19 KR KR1019890702338A patent/KR970009222B1/ko active IP Right Grant
- 1989-04-19 HU HU892751A patent/HU203888B/hu not_active IP Right Cessation
- 1989-04-19 WO PCT/JP1989/000423 patent/WO1989010365A1/en active IP Right Grant
- 1989-12-21 NO NO895165A patent/NO173501C/no unknown
- 1989-12-22 FI FI896251A patent/FI90870C/fi not_active IP Right Cessation
- 1989-12-22 DK DK659089A patent/DK659089A/da not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO1989010365A1 (en) | 1989-11-02 |
FI896251A0 (fi) | 1989-12-22 |
DK659089D0 (da) | 1989-12-22 |
EP0339358A1 (en) | 1989-11-02 |
EP0339358B1 (en) | 1994-07-13 |
NO895165D0 (no) | 1989-12-21 |
FI90870C (fi) | 1994-04-11 |
HU892751D0 (en) | 1990-03-28 |
FI90870B (fi) | 1993-12-31 |
KR900700480A (ko) | 1990-08-13 |
KR970009222B1 (ko) | 1997-06-09 |
JP2890448B2 (ja) | 1999-05-17 |
DK659089A (da) | 1989-12-22 |
JPH02275878A (ja) | 1990-11-09 |
ATE108450T1 (de) | 1994-07-15 |
NO173501B (no) | 1993-09-13 |
HU203888B (en) | 1991-10-28 |
NO895165L (no) | 1989-12-21 |
DE68916685T2 (de) | 1995-02-09 |
DE68916685D1 (de) | 1994-08-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI875502A (fi) | Morfolinoetylester av mykofenolsyra och dess derivat | |
NO173824C (no) | Analogifremgangsmaate ved fremstilling av immunomodulerende azaspiraner | |
NZ329374A (en) | Tricyclic amide and urea derivatives, preparation thereof | |
NL300298I1 (nl) | Nieuwe 3-piperidinyl-1,2-benzisoxazolen | |
NO178969C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive, substituerte kinazolinoner | |
NO902301L (no) | Fremgangsmaate for fremstilling av diarylstyrylkinolin-disyrer. | |
CY2529B1 (en) | New substituted azetidinones as anti-inflammatory and antidegenerative agents | |
AU3699193A (en) | Pharmaceutical composition containing quinoline and quinazoline derivatives and novel compounds therefor | |
IL99829A0 (en) | Heteroaroyl derivatives of monocyclic beta-lactams,pharmaceutical compositions containing the same and processes for the preparation thereof | |
NO173444C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive 4-(4'- fluorfenyl-)-tienopyridin-derivater | |
NO173501C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrazolo-pyridinforbindelser | |
CA2095361A1 (en) | Optical isomers of 7-¬3-(1,1-dialkylmethyl-1-amino)-1-pyrrolidinyl|-quinolones and naphthyridones as antibacterial agents | |
ATE178328T1 (de) | Loracarbef isopropanolat und umwandlungsverfahren vom isopropanolat in loracarbef monohydrat | |
NO306302B1 (no) | FremgangsmÕte for fremstilling av krystallinsk loracarbef-monohydrat | |
DK1264836T3 (da) | Fremgangsmåde til fremstilling af indolopyrrolocarbaxolderivater | |
IT1247921B (it) | Composti ad attivita' anticolinesterasi, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono | |
FI922519A (fi) | Menetelmä farmaseuttisesti käyttökelpoisten pilokarpiinijohdannaisten valmistamiseksi | |
FI922518A (fi) | Menetelmä farmaseuttisesti käyttökelpoisten pilokarpiinijohdannaisten valmistamiseksi |